What we can say honestly
This site does not quote a single survival percentage for “subdural hematoma.” Published numbers mix very different patients: a comatose acute bleed after high-energy trauma is not the same disease as a walking older adult with a chronic collection.
Ask your team about your exam, your scan, and the next decision—not about a statistic from a mixed population.
What outcomes depend on
- How alert the person is now (including GCS when it is used).
- Whether the bleed is acute, chronic, or mixed.
- Size, mass effect, and midline shift.
- Age and other medical problems.
- Blood-thinner exposure and whether it can be managed safely.
- How quickly dangerous pressure is recognized and treated.
- Whether a chronic collection recurs after drainage.
Acute versus chronic
Severe acute subdural hematoma associated with major trauma can have a grave course. Many chronic collections, by contrast, are treated in a planned way and a substantial number of patients improve as pressure is relieved and the fluid slowly resolves. That contrast is why this guide separates acute from chronic disease.
Function, not only survival
Families often care most about walking, thinking, and independence. Those outcomes take time to declare themselves and may need rehabilitation. A better scan does not always mean a better week, and a slower scan does not always mean a worse life. Follow the exam and the plan together.
What the MMAE trials do—and do not—show
EMBOLISE, STEM, and MAGIC-MT primarily tested recurrence, reoperation, or composite treatment failure—not a universal survival benefit. They also reported important safety events, including stroke. Read them as evidence for a specific tool in chronic care, not as a forecast of your recovery. The research page keeps the numbers in context.
Sources & further reading
- MedlinePlus / National Library of Medicine — Subdural hematoma
- Davies et al. EMBOLISE — Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma. NEJM, 2024.
- Fiorella et al. STEM — Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma. NEJM, 2025 (online 2024).
- Liu et al. MAGIC-MT — Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma. NEJM, 2024.
Educational content from Neurovascular Centers. Individual treatment decisions require a clinical examination and review of your imaging.